Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets (Q38207841)

24776703

31 August 2017

title

Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets (English)

1 reference

31 August 2017

Fan Jiang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776703%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Jianmin Yang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776703%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Yongtao Zhang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776703%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Mei Dong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776703%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Shuangxi Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776703%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Qunye Zhang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776703%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Fang Fang Liu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776703%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Kai Zhang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776703%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Cheng Zhang

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776703%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

language of work or name

English

0 references

publication date

29 April 2014

1 reference

24776703

Nature Reviews Cardiology

31 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776703%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776703%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776703%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

413-426

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776703%20AND%20SRC:MED&resulttype=core&format=json

The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Targeting the renin-angiotensin-aldosterone system in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

A new look at the renin-angiotensin system--focusing on the vascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Renin-angiotensin system blockade and cardiovascular and renal protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Renin-angiotensin system: upgrade of recent knowledge and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

On the local cardiac renin angiotensin system. Basic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

ACE2, angiotensin-(1–7), and Mas: the other side of the coin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Three key proteases--angiotensin-I-converting enzyme (ACE), ACE2 and renin--within and beyond the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-converting enzyme 2: the first decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Adenoviral delivery of angiotensin-(1-7) or angiotensin-(1-9) inhibits cardiomyocyte hypertrophy via the mas or angiotensin type 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-9) attenuates cardiac fibrosis in the stroke-prone spontaneously hypertensive rat via the angiotensin type 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Selective and specific regulation of ectodomain shedding of angiotensin-converting enzyme 2 by tumor necrosis factor alpha-converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Role of circulating angiotensin converting enzyme 2 in left ventricular remodeling following myocardial infarction: a prospective controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Novel peptide inhibitors of angiotensin-converting enzyme 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Regulation of alveolar epithelial cell survival by the ACE-2/angiotensin 1-7/Mas axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Species-specific inhibitor sensitivity of angiotensin-converting enzyme 2 (ACE2) and its implication for ACE2 activity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Phase I and pharmacokinetic study of angiotensin-(1-7), an endogenous antiangiogenic hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-7): pharmacological properties and pharmacotherapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-7) in kidney disease: a review of the controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin 1-7 improves insulin sensitivity by increasing skeletal muscle glucose uptake in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Beneficial versus harmful effects of Angiotensin (1-7) on impulse propagation and cardiac arrhythmias in the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Molecular Mechanisms Involved in the Angiotensin-(1-7)/Mas Signaling Pathway in Cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Control of adipogenesis by the autocrine interplays between angiotensin 1-7/Mas receptor and angiotensin II/AT1 receptor signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-7) stimulates the phosphorylation of Akt in rat extracardiac tissues in vivo via receptor Mas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Different effects of angiotensin II and angiotensin-(1-7) on vascular smooth muscle cell proliferation and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-7) enhances angiotensin II induced phosphorylation of ERK1/2 in mouse bone marrow-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-7) activates growth-stimulatory pathways in human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-7)-induced activation of ERK1/2 is cAMP/protein kinase A-dependent in glomerular mesangial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin (1-7) increases the potassium current and the resting potential of arterial myocytes from vascular resistance vessels of normal adult rats: Pathophysiological implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Involvement of the Gi/o/cGMP/PKG pathway in the AT2-mediated inhibition of outer cortex proximal tubule Na+-ATPase by Ang-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Genetically altered animal models for Mas and angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Impairment of In Vitro and In Vivo Heart Function in Angiotensin-(1-7) Receptor Mas Knockout Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Regulation of angiotensin-converting enzyme 2 and Mas receptor by Ang-(1-7) in heart and kidney of spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

The cardiac expression of Mas receptor is responsive to different physiological and pathological stimuli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Ablation of angiotensin (1-7) receptor Mas in C57Bl/6 mice causes endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Knockout of angiotensin 1-7 receptor Mas worsens the course of two-kidney, one-clip Goldblatt hypertension: roles of nitric oxide deficiency and enhanced vascular responsiveness to angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Mas oncogene signaling and transformation require the small GTP-binding protein Rac

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Inhibition of human lung cancer cell growth by angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Up-regulation of the angiotensin II type 1 receptor by the MAS proto-oncogene is due to constitutive activation of Gq/G11 by MAS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Effects of angiotensin IV and angiotensin-(1-7) on basal and angiotensin II-stimulated cytosolic Ca2+ in mesangial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin (1-7) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Characterization of a new angiotensin antagonist selective for angiotensin-(1–7): Evidence that the actions of angiotensin-(1–7) are mediated by specific angiotensin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Characterization of a new selective antagonist for angiotensin-(1-7), D-pro7-angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

AVE 0991, a nonpeptide mimic of the effects of angiotensin-(1-7) on the endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Vascular Relaxation, Antihypertensive Effect, and Cardioprotection of a Novel Peptide Agonist of the Mas Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

1A-779 attenuates angiotensin-(1-7) depressor response in salt-induced hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Gender differences in the attenuation of salt-induced hypertension by angiotensin (1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Impairment of the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Chronic infusion of angiotensin-(1-7) into the lateral ventricle of the brain attenuates hypertension in DOCA-salt rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Central endogenous angiotensin-(1-7) protects against aldosterone/NaCl-induced hypertension in female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Role of angiotensin-(1-7) in rostral ventrolateral medulla in blood pressure regulation via sympathetic nerve activity in Wistar-Kyoto and spontaneous hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Diuresis and natriuresis produced by long term administration of a selective Angiotensin-(1–7) antagonist in normotensive and hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Effects of truncated angiotensins in humans after double blockade of the renin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Co-localization of angiotensin-converting enzyme 2-, octomer-4- and CD34-positive cells in rabbit atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Expression of angiotensin-converting enzyme 2 and its end product angiotensin 1-7 is increased in diabetic atheroma: implications for inflammation and neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin converting enzyme 2 and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-converting enzyme 2 deficiency in whole body or bone marrow-derived cells increases atherosclerosis in low-density lipoprotein receptor-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-7) regulates Angiotensin II-induced VCAM-1 expression on vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

ACE2 gene expression is up-regulated in the human failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin converting enzyme 2 gene expression increased compensatory for left ventricular remodeling in patients with end-stage heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Increased expression of the renin-angiotensin system and mast cell density but not of angiotensin-converting enzyme II in late stages of human heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Plasma ACE2 activity is an independent prognostic marker in Chagas' disease and equally potent as BNP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

ACE2 improves right ventricular function in a pressure overload model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin 1-7 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db/db mice by reducing lipotoxicity and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Reduced isoproterenol-induced renin-angiotensin changes and extracellular matrix deposition in hearts of TGR(A1-7)3292 rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Circulating rather than cardiac angiotensin-(1-7) stimulates cardioprotection after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin(1-7) Blunts Hypertensive Cardiac Remodeling by a Direct Effect on the Heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Attenuation of isoproterenol-induced cardiac fibrosis in transgenic rats harboring an angiotensin-(1-7)-producing fusion protein in the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin (1-7) prevent heart dysfunction and left ventricular remodeling caused by renal dysfunction in 5/6 nephrectomy mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-7) and low-dose angiotensin II infusion reverse salt-induced endothelial dysfunction via different mechanisms in rat middle cerebral arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

The expression of angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas receptor axis are upregulated after acute cerebral ischemic stroke in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Suppressing inflammation by inhibiting the NF-κB pathway contributes to the neuroprotective effect of angiotensin-(1-7) in rats with permanent cerebral ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Anti-inflammatory effects of angiotensin-(1-7) in ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Differential regulation of circulating and renal ACE2 and ACE in hypertensive mRen2.Lewis rats with early-onset diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Effect of insulin on ACE2 activity and kidney function in the non-obese diabetic mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin 1-7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Increased circulating angiotensin-(1–7) protects white adipose tissue against development of a proinflammatory state stimulated by a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Oral administration of angiotensin-(1-7) ameliorates type 2 diabetes in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

The renin angiotensin aldosterone system and insulin resistance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Human recombinant ACE2 reduces the progression of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Phase I/II dose escalation study of angiotensin 1-7 [A(1-7)] administered before and after chemotherapy in patients with newly diagnosed breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Oral and pulmonary delivery of thioether-bridged angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

The effect of the thioether-bridged, stabilized Angiotensin-(1-7) analogue cyclic ang-(1-7) on cardiac remodeling and endothelial function in rats with myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Beneficial effects of long-term administration of an oral formulation of Angiotensin-(1-7) in infarcted rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Oral formulation of angiotensin-(1-7) improves lipid metabolism and prevents high-fat diet-induced hepatic steatosis and inflammation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-7): beyond the cardio-renal actions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-converting enzyme 2: central regulator for cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin-angiotensin system: a patent review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

ACE2 activation promotes antithrombotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Converting enzyme determines plasma clearance of angiotensin-(1-7)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Pathways for angiotensin-(1---7) metabolism in pulmonary and renal tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Effect of angiotensin-(1-7) on reperfusion arrhythmias in isolated rat hearts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1–7) binding at angiotensin II receptors in the rat brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-7) binds at the type 1 angiotensin II receptors in rat renal cortex

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Selective expression of c-mas proto-oncogene in rat cerebral endothelial cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-7) inhibits vascular smooth muscle cell growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

The genetic deletion of Mas abolishes salt induced hypertension in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-converting enzyme 2 antagonizes angiotensin II-induced pressor response and NADPH oxidase activation in Wistar-Kyoto rats and spontaneously hypertensive rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1-7) in normotensive and hypertensive rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-7) induces bradykinin-mediated hypotensive responses in anesthetized rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-7) attenuates hypertension in exercise-trained renal hypertensive rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Changes in the Baroreflex Control of Heart Rate Produced by Central Infusion of Selective Angiotensin Antagonists in Hypertensive Rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Role of angiotensin-(1-7) in the modulation of the baroreflex in renovascular hypertensive rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Effects of angiotensin-(1-7) on forearm circulation in normotensive subjects and patients with essential hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

ACE2 overexpression ameliorates left ventricular remodeling and dysfunction in a rat model of myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Cardiac Angiotensin-(1-7) in Ischemic Cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1–7) Attenuates the Development of Heart Failure After Myocardial Infarction in Rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

The nonpeptide angiotensin-(1-7) receptor Mas agonist AVE-0991 attenuates heart failure induced by myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-7) causes endothelium-dependent relaxation in canine middle cerebral artery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-7) attenuates diabetic nephropathy in Zucker diabetic fatty rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Effect of angiotensin-(1-7) and bradykinin in patients with heart failure treated with an ACE inhibitor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Angiotensin-(1-7) with thioether bridge: an angiotensin-converting enzyme-resistant, potent angiotensin-(1-7) analog

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

An oral formulation of angiotensin-(1-7) produces cardioprotective effects in infarcted and isoproterenol-treated rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.59

Characterization of the rat mas oncogene and its high-level expression in the hippocampus and cerebral cortex of rat brain

31 March 2020

1 reference

12 December 2020

Differential regulation of central vasopressin in transgenic rats harboring the mouse Ren-2 gene

1 reference

12 December 2020

Signal transduction mechanisms involved in angiotensin-(1-7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells

1 reference

12 December 2020

Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats

1 reference

12 December 2020

Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition

1 reference

12 December 2020

AVE 0991-angiotensin-(1-7) receptor agonist, inhibits atherogenesis in apoE-knockout mice

1 reference

12 December 2020

Differential baroreceptor reflex modulation by centrally infused angiotensin peptides

1 reference

12 December 2020

Angiotensin-(1-7) receptor Mas agonist ameliorates progress of atherosclerosis in apoE-knockout mice

1 reference

12 December 2020

Angiotensin-(1-7): a new hormone of the angiotensin system

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRCARDIO.2014.59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776703%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776703%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

24776703

1 reference